BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2391974)

  • 1. Hemodynamic effects and oxygen transport properties of a new blood substitute in a model of massive blood replacement.
    Vlahakes GJ; Lee R; Jacobs EE; LaRaia PJ; Austen WG
    J Thorac Cardiovasc Surg; 1990 Sep; 100(3):379-88. PubMed ID: 2391974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The physiologic effects of oxygen transport by hemoglobin solutions.
    Moores WY; White FC; Bloor C; Greenburg AG; Mack R; Willford DC
    Prog Clin Biol Res; 1983; 122():89-99. PubMed ID: 6878384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemoglobin blood substitutes in extended preoperative autologous blood donation: an experimental study.
    Slanetz PJ; Lee R; Page R; Jacobs EE; LaRaia PJ; Vlahakes GJ
    Surgery; 1994 Feb; 115(2):246-54. PubMed ID: 8310414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive properties of synthetic blood substitutes.
    de Figueiredo LF
    Medicina (B Aires); 1998; 58(4):403-10. PubMed ID: 9816703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxygen transport by erythrocyte/hemoglobin solution mixtures in an in vitro capillary as a model of hemoglobin-based oxygen carrier performance.
    Page TC; Light WR; McKay CB; Hellums JD
    Microvasc Res; 1998 Jan; 55(1):54-64. PubMed ID: 9473409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Contributions and prospects of hemoglobin derivatives].
    Remy B; Deby-Dupont G; Lamy M
    Schweiz Med Wochenschr; 1997 Jun; 127(25):1088-96. PubMed ID: 9312831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a bovine stroma-free hemoglobin solution as a blood substitute.
    Feola M; Gonzalez H; Canizaro PC; Bingham D; Periman P
    Surg Gynecol Obstet; 1983 Nov; 157(5):399-408. PubMed ID: 6635908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemoglobin-based oxygen carrier preserves submaximal exercise capacity in humans.
    Hughes GS; Yancey EP; Albrecht R; Locker PK; Francom SF; Orringer EP; Antal EJ; Jacobs EE
    Clin Pharmacol Ther; 1995 Oct; 58(4):434-43. PubMed ID: 7586936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of erythrocyte substitutes.
    Biro GP
    Can Med Assoc J; 1983 Aug; 129(3):237-44. PubMed ID: 6344974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the acute hemodynamic and delayed effects of 50% exchange transfusion with two different cross-linked hemoglobin based oxygen carrying solutions and Pentastarch.
    Bonegio RG; Fuhro R; Ragno G; Robert Valeri C; Lieberthal W
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(2):145-57. PubMed ID: 16537171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemoglobin solutions.
    Creteur J; Vincent JL
    Crit Care Med; 2003 Dec; 31(12 Suppl):S698-707. PubMed ID: 14724468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current research on oxygen carriers for transfusion: hemoglobin solutions and fluorocarbon emulsions].
    Labrude P
    Ann Pharm Fr; 1992; 50(5-6):250-66. PubMed ID: 1307671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of stroma-free hemoglobin solutions as blood substitute].
    Förster H; Hoos I; Schneider M; Hauk H
    Infusionsther Klin Ernahr; 1977 Apr; 4(2):122-6. PubMed ID: 558158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinctive characteristics of pyridoxalated-polymerized hemoglobin.
    DeVenuto F; Zegna AI
    Prog Clin Biol Res; 1983; 122():29-39. PubMed ID: 6878372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemoglobin-based oxygen carriers: first, second or third generation? Human or bovine? Where are we now?
    Napolitano LM
    Crit Care Clin; 2009 Apr; 25(2):279-301, Table of Contents. PubMed ID: 19341909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gas exchange and hemodynamics following complete replacement of blood with a solution of purified hemoglobin].
    Fedorov NA; Iarochkin VS; Koziner VB
    Biull Eksp Biol Med; 1977 Oct; 84(10):402-5. PubMed ID: 912051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood substitutes as pharmacotherapies in clinical practice.
    Jahr JS; Walker V; Manoochehri K
    Curr Opin Anaesthesiol; 2007 Aug; 20(4):325-30. PubMed ID: 17620840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymerized pyridoxylated hemoglobin: a red cell substitute with normal oxygen capacity.
    Sehgal LR; Gould SA; Rosen AL; Sehgal HL; Moss GS
    Surgery; 1984 Apr; 95(4):433-8. PubMed ID: 6710339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of injectable oxygen carriers.
    Zuck TF; Riess JG
    Crit Rev Clin Lab Sci; 1994; 31(4):295-324. PubMed ID: 7888075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histology and ultrastructure of liver and kidney following blood exchange with ultrapurified, polymerised bovine hemoglobin in comparison with hydroxyethyl starch.
    Lipfert B; Standl T; Düllmann J; Helmchen U; Schulte am Esch J; Lorke DE
    Lab Invest; 1999 May; 79(5):573-82. PubMed ID: 10334568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.